The Washington Examiner reported Friday revealed that Kimberly Guilfoyle had tested positive for the coronavirus.
Guilfoyle is a top fundraising official and surrogate for the Trump 2020 campaign, and she is also the girlfriend of the president’s eldest son, Donald Trump, Jr.
Guilfoyle tests positive for COVID-19
Fox News published comments regarding Guilfoyle’s condition from Sergio Gor, who serves as chief of staff for the Trump Victory Finance Committee.
“After testing positive, Kimberly was immediately isolated to limit any exposure,” Gor explained in a statement to the network on Saturday. “She’s doing well, and will be retested to ensure the diagnosis is correct since she’s asymptomatic, but as a precaution will cancel all upcoming events,” he added.
Gor went on to assure that “Donald Trump Jr. had thus far tested negative but as a precaution is also self-isolating and is canceling all public events.”
Fox News reported that Guilfoyle’s positive test result came while she was in South Dakota to hear President Trump give an address at Mount Rushmore on July 3, though according to The New York Times, neither Guilfoyle nor Trump Jr. traveled aboard Air Force One, and the pair had not been in close contact with the president during the period in question.
Study supports hydroxychloroquine use
“Researchers at the Henry Ford Health System in Southeast Michigan have found that early administration of the drug hydroxychloroquine makes hospitalized patients substantially less likely to die,” the network reported.
According to the study published in the International Journal of Infectious Diseases, there was a “66% hazard ratio reduction” in coronavirus patients who took the anti-malarial drug and a 71% reduction in those who were given hydroxychloroquine and azithromycin” as compared to patients who received neither treatment method.
President Trump has frequently touted the potential benefits of hydroxychloroquine, and he revealed in May that he was taking it himself as a precautionary measure, as Fox News reported.
A statement from the Trump campaign on the study’s findings read:
Fortunately, the Trump Administration secured a massive supply of hydroxychloroquine for the national stockpile months ago. Yet this is the same drug that the media and the Biden campaign spent weeks trying to discredit and spread fear and doubt around because President Trump dared to mention it as a potential treatment for coronavirus.
Whether there will be an imminent mea culpa from the journalists who, among other things, slammed the president’s prior enthusiasm for the drug as akin to a “fondness for snake oil” remains to be seen.